Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder (Q33926476)

30 July 2017

0 references

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

30 July 2017

1 reference

1 reference

inferred from title

author

Christopher Pittenger

object named as

C Pittenger

5

0 references

author name string

M H Bloch

1

1 reference

30 July 2017

J McGuire

2

1 reference

30 July 2017

A Landeros-Weisenberger

3

1 reference

30 July 2017

J F Leckman

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

26 May 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

15

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

850-855

1 reference

Meta-analysis of the symptom structure of obsessive-compulsive disorder

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Practice guideline for the treatment of patients with obsessive-compulsive disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

A multidimensional model of obsessive-compulsive disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Treatment non-response in OCD: methodological issues and operational definitions

5 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

5 July 2018

https://api.crossref.org/works/10.1038%2FMP.2009.50

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Serotonergic antidepressants and their efficacy in obsessive compulsive disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FMP.2009.50

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FMP.2009.50

Epidemiology of obsessive-compulsive disorder

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2888928

Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder

29 October 2018

1 reference

12 December 2020

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

12 December 2020

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

12 December 2020

Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2009.50

1 reference

30 July 2017

1 reference

30 July 2017

1 reference